Chugai Pharmaceutical Co. reported a 3.3% increase in net income to 305.6 billion yen and a 5.0% increase in revenue to 911.6 billion yen on a IFRS basis for the nine month period. Core net income also rose by 6.2% to 320.0 billion yen with core revenue at 911.6 billion yen. The company attributed the growth to steady performance in both domestic and overseas product sales.

For more earnings news and updates, visit rttnews.com.

Read more at Nasdaq: Chugai Pharmaceutical 9-month Net Income Rises